The Beginning of Genomic Therapies for ALS
The Beginning of Genomic Therapies for ALS
About this item
Full title
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Amyotrophic lateral sclerosis (ALS) is a heterogeneous disorder of progressive degeneration of upper and lower motor neurons that typically leads to death from ventilatory failure within 5 years after the onset of illness. Genetic factors account for half of the variance in the risk of the disorder.
1
Up to 15% of patients with ALS have a fam...
Alternative Titles
Full title
The Beginning of Genomic Therapies for ALS
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2422007358
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2422007358
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMe2012930
